4th Quarter - Report — MCDERMOTT WILL & SCHULTE LLP for GENOMIC HEALTH INC (2008)

Firm

MCDERMOTT WILL & SCHULTE LLP

Client

GENOMIC HEALTH INC

Income

$170,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.

Lobbyist	Covered position, as disclosed
ERIC HARGAN	Services
PAUL D HATCH	—
PAUL WILLIAM RADENSKY	—
SHEILA D WALCOFF	Committee, U.S. House of Representatives
ERIC ZIMMERMAN	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.

Lobbyist	Covered position, as disclosed
ERIC HARGAN	Services
PAUL D HATCH	—
PAUL WILLIAM RADENSKY	—
SHEILA D WALCOFF	Committee, U.S. House of Representatives
ERIC ZIMMERMAN	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Health Issues HCR

FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.

Lobbyist	Covered position, as disclosed
ERIC HARGAN	Services
PAUL D HATCH	—
PAUL WILLIAM RADENSKY	—
SHEILA D WALCOFF	Committee, U.S. House of Representatives
ERIC ZIMMERMAN	—

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.